Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 24/06/2026 am IST
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 24/06 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 24/06 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 626.66Cr 571.52Cr 528.42Cr 476.88Cr 898.13Cr 59TCr 933.54Cr 6.38TCr 2.52TCr 32TCr 2.35TCr 2.3TCr 1LCr | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 609.04Cr 555.45Cr 513.56Cr 463.47Cr 872.87Cr 57TCr 907.29Cr 6.2TCr 2.45TCr 31TCr 2.28TCr 2.24TCr 97TCr | EV / Sales 2024 |
-
| EV / Sales 2025 | 23,18,10,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 6 months | +2.17% | ||
| Current year | +61.94% |
| Current year | 21.5 | 40.56 | |
| 1 year | 21.5 | 40.56 | |
| 3 years | 5.58 | 40.56 | |
| 5 years | 2.88 | 40.56 | |
| 10 years | 2.88 | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -1,99,63,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 26/03/26 | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.80% | -.--% | +42.81% | +475.28% | 626.65Cr | ||
| -1.34% | -3.09% | +56.10% | +68.83% | 6.55TCr | ||
| +0.59% | -1.83% | +8.98% | +90.01% | 5.89TCr | ||
| +0.54% | +0.45% | +25.96% | +87.77% | 5.52TCr | ||
| -2.34% | -3.90% | +10.90% | +115.97% | 4.61TCr | ||
| +0.09% | -6.08% | +18.67% | +25.90% | 4.25TCr | ||
| -2.58% | +0.24% | +18.54% | +41.28% | 3.56TCr | ||
| -1.76% | -11.56% | +126.44% | +649.27% | 3.46TCr | ||
| -0.17% | -1.83% | +82.46% | +57.69% | 3.25TCr | ||
| -1.69% | -0.79% | -40.58% | +382.68% | 2.63TCr | ||
| Average | -0.79% | -2.87% | +35.03% | +199.47% | 4TCr | |
| Weighted average by Cap. | -0.81% | -3.21% | +34.31% | +148.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.68 12.65 11.41 21.5 1.4T 22.35 152.76 60.39 756.58 56.27 55.1 2.39T |
| Net income | -24Cr -22Cr -20Cr -18Cr -34Cr -2.2TCr -35Cr -240.1Cr -95Cr -1.19TCr -88Cr -87Cr -3.75TCr | -20Cr -18Cr -17Cr -15Cr -28Cr -1.85TCr -29Cr -201.17Cr -80Cr -996.32Cr -74Cr -73Cr -3.15TCr |
| Net Debt | -36Cr -33Cr -31Cr -28Cr -52Cr -3.4TCr -54Cr -371.06Cr -146.68Cr -1.84TCr -136.69Cr -133.83Cr -5.8TCr | -18Cr -16Cr -15Cr -13Cr -25Cr -1.65TCr -26Cr -179.44Cr -71Cr -888.72Cr -66Cr -65Cr -2.81TCr |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
















